Association Between Hepatitis C Infection and Renal Cell Carcinoma

Henry Ford Health System240 enrolled

Overview

The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).

Study Type

OBSERVATIONAL

Enrollment

240

Conditions

Hepatitis C Renal Cell Carcinoma Colorectal Cancer

Interventions

Hepatitis C testingOTHER

Hepatitis C antibody, Hepatitis C RNA quantitative and for those who test positive Hepatitis C genotype

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months. * Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months Exclusion Criteria: * Patients who are unwilling to provide consent * Patients who decline to complete a questionnaire * Patient in who blood sample cannot be obtained * Diagnosis of renal cell carcinoma or colon cancer greater than 6 months

Locations (1)

Henry Ford Hospital

Detroit, Michigan, United States

Outcomes

Primary Outcomes

Prevalence of hepatitis C in renal cell carcinoma patients

Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.